BEAT

Bearish

Benchmark cuts Heartbeam stock price target on dilution to $5 By Investing.com

Benchmark has lowered its price target for Heartbeam Inc. (NASDAQ:BEAT) to $5.00 from $8.00 due to the dilutive effect of a recent $11.5 million equit...

Investing.com Canada 1 week ago 0

Bullish

HeartBeam, Inc. (NASDAQ:BEAT) Q1 2026 Earnings Call Transcript

HeartBeam, Inc. (NASDAQ:BEAT) reported its Q1 2026 earnings, beating EPS expectations with $-0.12. The company highlighted significant progress in com...

Insider Monkey 1 week ago 0